With one of the lowest vaccination rates in South America, Paraguay is in a race against time to make progress in its immunization effort, turning now to non-approved vaccines. This week, health authorities in Asunción greenlit the purchase of 1 million UB-612 vaccine doses produced by U.S company Vaxxinity.
The Vaxxinity immunizer has not yet been approved by U.S regulators, meaning the deal will only benefit the country in the coming months. To make matters worse, Paraguay doesn’t have its own regulatory agency, depending on decisions made by neighboring countries.
During the week, the 7.1-million-people nation also welcomed a 540,000-dose batch backed by the United Nations Children’s Fund (Unicef).
Improving vaccination in Paraguay is urgent: as of June 18, only 1.5 percent of the country’s population have been vaccinated.
The Abu Dhabi National Oil Company (ADNOC) is no longer interested in buying Novonor's controlling…
Brazilian railway operator Rumo announced a partial interruption of its activities in southern Brazil on…
Welcome to our Tech Roundup, where we bring you the biggest stories in technology and…
For some time, the decisions of Alexandre de Moraes, justice of Brazil’s Supreme Court and…
Panama was once a part of Colombia. Its canal, a monumental engineering achievement of its…
The specialization trend among corporate board members It is not only a matter of perception:…